Figure 3
From: Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans
Levels of let-7b in plasma samples of patients with ischemic stroke at 24 h, 1 w, 4 w, 24 w and 48 w after the onset of symptoms. (A) The levels of let-7b-LA at different time points; (B) The levels of let-7b-SA at different time points; (C) The levels of let-7b-CEmb at different time points; (D) The levels of let-7b-UDN at different time points (* vs. control, p < 0.05).